Omeprol (Omeprazole)

Omeprazole, the active ingredient in Omeprol, is a proton pump inhibitor presented as a / oral use. It reduces gastric acid secretion and is used to manage conditions such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults and children.

GNH USA supplies Omeprol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazole is used to treat acid‑related disorders by decreasing stomach acidity.

- Gastro‑oesophageal reflux disease (GERD): helps heal erosive esophagitis and relieve heartburn. - Peptic ulcer disease: promotes ulcer healing and reduces recurrence. - Zollinger‑Ellison syndrome: controls gastric acid hypersecretion. - Helicobacter pylori eradication regimens: used as part of combination therapy to improve eradication rates. - NSAID‑associated ulcer prophylaxis: lowers risk of ulcer formation in at‑risk patients.

Omeprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild and transient. - Diarrhea: usually self‑limiting. - Nausea: occasional mild upset. - Abdominal pain: mild cramping. - Flatulence: excess gas. - Constipation: occasional bowel changes.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis risk. - Hypomagnesemia: low magnesium levels with prolonged use. - Vitamin B12 deficiency: reduced absorption over time. - Acute interstitial nephritis: kidney inflammation. - Stevens‑Johnson syndrome: rare severe skin reaction. - Fracture risk: possible reduced bone density with long‑term therapy.

When using Omeprazole, consider the following precautions:

- Assess renal function: dose adjustment may be needed in severe impairment. - Monitor magnesium levels: long‑term therapy can lower serum magnesium. - Evaluate bone health: prolonged use may affect calcium absorption. - Review concomitant medications: potential for altered drug absorption. - Pregnancy and lactation: use only if clearly needed after risk‑benefit assessment. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Omeprazole can affect the plasma concentrations of several co‑administered drugs.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, consider alternative therapy. - Atazanavir: markedly decreased absorption, contraindicated. - Dasatinib: reduced exposure, may require dose adjustment.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR, monitor coagulation parameters. - Phenytoin: decreased serum levels, monitor seizure control. - Methotrexate: increased toxicity risk, especially at high doses. - Digoxin: modest increase in serum concentration, observe for signs of toxicity.